Dermatological healing kit, components therefor, and process for making
AssigneeGeneda Corporation
InventorChanda Zaveri
Life of this patent
Estimating the term…
Abstract
The invention is a dermatological healing kit having a pigment stabilizer component, and an antiinflammatory emollient component, and these components each by themselves, wherein the pigment stabilizer contains a mixture of glycerine, butylene glycol, bearberry extract, and mitracarpe extract; magnesium ascorbyl phosphate; and tricholoma matsutake singer; and the antiinflammatory emollient component contains xanthoxylum bungeanum planch; decarboxy camosine chlorhydrate; polygonum multiforum thumb; rubus thunbergii hance.cum spp.; and an aqueous mixture of siegerbecka orientals extract.
Claims16
A pigment stabilizer which comprises the ingredients:
- (i) from about 1% to about 15% a mixture of glycerine, butylene glycol, bearberry extract, and mitracarpus extract;
- (ii) from about 0.01% to about 1.5% magnesium ascorbyl phosphate;
- and (iii) from about 0.01 to about 5% tricholoma matsutake extract.
A dermatological healing kit the components of which comprise the pigment stabilizer of claim, and an antiinflammatory emollient.
A pigment stabilizer which comprises the ingredients:
- (i) about 7.76% of a mixture of glycerin, butylene glycol, bearberry extract, and mitracarpus extract;
- (ii) about 0.68% of magnesium ascorbyl phosphate;
- (iii) about 0.68% of tricholoma matsutake extract;, (iv) about 6.76% of a mixture of dithiaoctanediol, gluconic acid, sutilains, and beta carotene;
- (v) about 6.76% of a mixture of lecithin, and bearberry extract;
- (vi) about 6.76% of ascorbyl methylsilanol pectinate;
- (vii) about 33.78% of an aqueous solution of lactobacillus/algae extract ferment;
- (viii) about 17.2% of aloe barbadensis gel;
- (ix) about 6.76% of a mixture of licorice extract, aspergillus ferment, and ethoxydiglycol;
- (x) about 6.76% of aqueous glycolic acid;
- (xi) about 3.05% of a mixture of lecithin and xanthan gum;
- (xii) about 1.7% of licorice extract;
- and (xiii) about 1.35% kojic acid.
An antiinflammatory emollient which comprises the ingredients:
- (a) from about 3% to about 8% zanthoxylum bungeanum;
- (b) from about 1% to about 6% decarboxy carnosine HCl;
- (c) from about 1% to about 6% polygonum multiforum;
- (d) from about 1% to about 6% rubus thunbergii.cum spp.;
- and (e) from about 1% to about 5% an aqueous mixture of sigesbeckia orientalis extract.
A antiinflammatory emollient which comprises the ingredients:
- (a) about 7.11% of zanthoxylum bungeanum;
- (b) about 4.7% of decarboxy carnosine HCl;
- (c) about 4.7% of polygonum multiforum;
- (d) about 4.7% of rubus thunbergii.cum spp.;
- (e) about 2.36% of an aqueous mixture of sigesbecka orientalis extract;
- (f) about 46% of a mixture of mineral oil, hydrogenated butylene/ethylene/styrene terpolymer, and hydrogenated ethylene/propylene/styrene terpolymer;
- (g) about 4.7% of dimethylsilanol hyaluronate;
- (h) about 4.7% of sorbitol and yeast extract;
- (i) about 2.36% of a mixture of PEG-60 hydrogenated castor oil, PEG-8 and ceramide 2;
- (j) about 1.66% of an aqueous mixture of butylene glycol and chrysanthellum extract;
- (k) about 1% of a mixture of cetearyl alcohol and ceteareth-20;
- (l) about 2% of a mixture of glyceryl stearate and PEG-100 stearate;
- (m) about 1% of polysorbate-80;
- (n) about 4.7% of methylsilanol mannuronate;
- (o) about 2.36% of an aqueous solution of silanediol salicylate;
- (p) about 2.36% of a mixture of ethoxydiglycol, PEG-7 glyceryl cocoate, and centaurium erythraea extract;
- (q) about 2.36% of an aqueous mixture of glycerin and lactobacillus/skeletonema ferment and glyceryl skeletonema;
- (r) about 1.22% of chitosan succinamide;
- and (s) about 0.01% of an extract of lonicera japonica with water.
Dependencies are inferred from the claim text.